Evidence map›Paper›PMID 35298348›Full record

ArticleNucleus (Austin, Tex.)2022

Ulrike Schweigel, Petros Batsios, Annette Müller-Taubenberger, Ralph Gräf, Marianne Grafe

Open access · goldAbstract read
In one paragraph

Article in Nucleus (Austin, Tex.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ulrike SchweigelDepartment of Cell Biology, University of Potsdam, Institute for Biochemistry and Biology, Potsdam-Golm, Germany.
Petros BatsiosDepartment of Cell Biology, University of Potsdam, Institute for Biochemistry and Biology, Potsdam-Golm, Germany.
Annette Müller-TaubenbergerDepartment of Cell Biology, LMU Munich, Biomedical Center, Planegg-Martinsried, Germany.
Ralph GräfDepartment of Cell Biology, University of Potsdam, Institute for Biochemistry and Biology, Potsdam-Golm, Germany.ORCID 0000-0001-5144-868X
Marianne GrafeDepartment of Cell Biology, University of Potsdam, Institute for Biochemistry and Biology, Potsdam-Golm, Germany.ORCID 0000-0002-4048-7891
University of Potsdam · DEUrologische Klinik München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dictyostelium amoebae perform a semi-closed mitosis, in which the nuclear envelope is fenestrated at the insertion sites of the mitotic centrosomes and around the central spindle during karyokinesis. During late telophase the centrosome relocates to the cytoplasmic side of the nucleus, the central spindle disassembles and the nuclear fenestrae become closed. Our data indicate that Dictyostelium spastin (DdSpastin) is a microtubule-binding and severing type I membrane protein that plays a role in this process. Its mitotic localization is in agreement with a requirement for the removal of microtubules that would hinder closure of the fenestrae. Furthermore, DdSpastin interacts with the HeH/ LEM-family protein Src1 in BioID analyses as well as the inner nuclear membrane protein Sun1, and shows subcellular co-localizations with Src1, Sun1, the ESCRT component CHMP7 and the IST1-like protein filactin, suggesting that the principal pathway of mitotic nuclear envelope remodeling is conserved between animals and Dictyostelium amoebae.

Indexed as

DictyosteliumNuclear EnvelopeAnimalsCell Nucleus DivisionMitosisSpastinSpastindictyosteliumESCRTLEM-domainmitosisnuclear envelopeSpastinsun1

Identifiers

PMID35298348
PMCPMC8932920
OpenAlexW4220912587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.